...
首页> 外文期刊>Clinical Genetics: An International Journal of Genetics in Medicine >Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis
【24h】

Detection of chromosomal aneuploidies in fetal cells isolated from maternal blood using single-chromosome dual-probe FISH analysis

机译:用单染色体双探针鱼分析检测母血分离的胎儿细胞中的染色体非细胞

获取原文
获取原文并翻译 | 示例

摘要

Detection of chromosomal aneuploidies using fetal cells isolated from maternal blood, for prenatal non-invasive genetic investigation, has been a long-sought goal of clinical genetics to replace amniocentesis and chorionic villous sampling to avoid any risk to the fetus. The purpose of this study was to develop a sensitive and specific new assay for diagnosing aneuploidy with circulating fetal cells isolated from maternal blood as previously reported using two novel approaches: (i) simultaneous immunocytochemistry (ICC) evaluation using a monoclonal antibody for i-antigen, followed by fluorescence in situ hybridization (FISH); (ii) dual-probe FISH analysis of interphase nuclei using two differently labeled probes, specific for different loci of chromosomes 21 and 18; in addition, short tandem repeats (STR) analysis on single cells isolated by micromanipulation was applied to confirm the presence of fetal cells in the cell sample enriched from maternal blood. Blood samples were obtained from women carrying trisomic fetuses, and from non-pregnant women and men as controls. Using ICC-FISH approach, a large heterogeneity in immunostaining pattern was observed, which is a source of very subjective signal interpretation. Differently, dual-probe FISH analysis provided for a correct diagnosis of all pregnancies: the mean percentage of trisomic cells was 0.5% (range, 0.36-0.76%), while the mean percentage of trisomic cells in the control group (normal pregnancies or non-pregnant women) was ≤0.20%. The application of the dual-probe FISH protocol on fetal cells isolated from maternal blood enables accurate molecular detection of fetal aneuploidy, thus providing a foundation for development of non-invasive prenatal diagnostic testing.
机译:使用胎儿细胞分离的母体细胞检测母体细胞,用于产前无侵入性遗传遗传调查,是临床遗传学的长期目标,以取代羊膜膜和绒毛膜绒毛采样,以避免胎儿的任何风险。本研究的目的是开发一种敏感性和特异性的新测定,用于使用两种新方法以前报道的母血分离的循环胎儿细胞的循环胎儿细胞:(i)使用单克隆抗体进行I-抗原的同时免疫细胞化学(ICC)评价,然后是原位杂交(鱼)的荧光; (ii)使用两种不同标记探针的双相核的双探针鱼分析,特异于染色体21和18的不同基因座;此外,应用微观素分离的单细胞的短串联重复(str)分析以确认富含产妇血液中的细胞样品中的胎儿细胞的存在。血样是从携带三种胎儿的妇女获得的血液样本,并从非孕妇和男性作为对照。使用ICC-Fish方法,观察到免疫染色模式中的大异质性,这是非常主观信号解释的源。不同,双重探测鱼分析为所有妊娠的正确诊断:三种细胞的平均百分比为0.5%(范围,0.36-0.76%),而对照组的三元组细胞的平均百分比(正常妊娠或非 - 孕妇女性)≤0.20%。双探针鱼协议对母血分离的胎儿细胞的应用能够精确分子检测胎儿非血管倍性,从而为非侵入性产前诊断测试的发展提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号